Last reviewed · How we verify
NCT05946720
Aggression From the Perspective of Patients and Nurses
NA trial testing Training including aggression and the use of BVC. in Aggression in 97 participants. Completed in 14 April 2022.
10 July 2021
Quick facts
| Lead sponsor | Muğla Sıtkı Koçman University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 97 |
| Start date | 1 July 2021 |
| Primary completion | 10 July 2021 |
| Estimated completion | 14 April 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Training including aggression and the use of BVC.
Conditions studied
- Aggression — all drugs for Aggression →
Sponsor
Muğla Sıtkı Koçman University
Who can join
Adults 18 to 65, any sex, with Aggression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The research, was planned in a randomized controlled design, aiming to evaluate the effect of the training given to nurses working in psychiatric clinics on the use of aggression and BVC (Broset Violence Checklist) on the nurses' perceptions of aggression and the compliance of the use of BVC, which they evaluated for the patients watched in the videos, with the BVC determined by expert opinion. The study was conducted in Adana Doctor Ekrem Tok Mental Health and Diseases Hospital between July 2021 and April 2022. A total of 97 nurses working in psychiatric clinics, 47 in the training group and 50 in the comparison group, participated in the study. A pre-test was administered to the nurses and nurses in the training group were randomized and given training including aggression and BVC use. After the training, a post-test was administered to all nurses.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05946720
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aggression
Currently open trials in the same condition.
- NCT07434479 — A Virtual Reality Mindfulness Application for Aggression in Schizophrenia · NA · recruiting
- NCT05928247 — Manualized Assessment and Treatment Model of Challenging Behavior · NA · recruiting
- NCT06902649 — Step-by-Step: Evaluation of a Stepped Care Model · NA · recruiting
- NCT06579950 — Assessing the Effects of Cool Roofs on Indoor Environments and Health · NA · recruiting
- NCT05925101 — Basic and Applied Research on Extinction Bursts · NA · recruiting
Other Muğla Sıtkı Koçman University trials
Trials by the same sponsor.
- NCT05046834 — Effect of Cold Application on Patient's Pain and Vital Signs During Chest Tube Removal. · NA · withdrawn
- NCT07323160 — Determining the Effect of Education Given to Patients Undergoing Outpatient Anal Fistula Surgery · NA · not yet recruiting
- NCT07308730 — Pain Diary Use After Laparoscopic Cholecystectomy · NA · recruiting
- NCT06704399 — Psychoeducation Based on Acceptance and Commitment Therapy · NA · not yet recruiting
- NCT07183956 — Comparison of the Silverman-Andersen Score and the Downes Score · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05946720 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Muğla Sıtkı Koçman University
- Last refreshed: 14 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05946720.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing